Review paper<br>
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Yasuo Yoshioka; Osamu Suzuki; Yuki Otani; Ken Yoshida; Takayuki Nose; Kazuhiko Ogawa

doi:10.5114/jcb.2014.42026

eISSN: 2081-2841
ISSN: 1689-832X

Journal of Contemporary Brachytherapy

Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links

Editorial System

Submit your Manuscript

1/2014
vol. 6

Send email

Copy url:

abstract:

Review paper
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Yasuo Yoshioka

,

Osamu Suzuki

,

Yuki Otani

,

Ken Yoshida

,

Takayuki Nose

,

Kazuhiko Ogawa

J Contemp Brachytherapy 2014; 6, 1: 91–98

DOI: https://doi.org/10.5114/jcb.2014.42026

Online publish date: 2014/04/03

View full text Get citation

High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer. Although clinical results are not yet mature enough, it is a highly promising approach in terms of potential benefits for both radiation physics and radiobiology. In this article, we describe our technique for monotherapeutic HDR prostate brachytherapy, as well as the rationale and theoretical background, with educational intent.

keywords:

Review paper High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Yasuo Yoshioka , Osamu Suzuki , Yuki Otani , Ken Yoshida , Takayuki Nose , Kazuhiko Ogawa

prostate cancer, radiotherapy, high-dose-rate (HDR) brachytherapy, monotherapy, hypofractionation

Review paper
High-dose-rate brachytherapy as monotherapy for prostate cancer: technique, rationale and perspective

Yasuo Yoshioka

,

Osamu Suzuki

,

Yuki Otani

,

Ken Yoshida

,

Takayuki Nose

,

Kazuhiko Ogawa